Generic placeholder image

Current Pharmaceutical Design

Author(s): Laura C. de Lima, Matheus A.S. Ramos, Luciani G. de Toledo, Camila F. Rodero, Felipe Hilário, Lourdes C. dos Santos, Marlus Chorilli and Taís M. Bauab*

DOI: 10.2174/1381612826666200317131041

DownloadDownload PDF Flyer Cite As
Syngonanthus nitens (Bong.) Ruhland Derivatives Loaded into a Lipid Nanoemulsion for Enhanced Antifungal Activity Against Candida parapsilosis

Page: [1556 - 1565] Pages: 10

  • * (Excluding Mailing and Handling)

Abstract

Background: Vaginal infections caused by non-albicans species have become common in women of all age groups. The resistance of species such as Candida parapsilosis to the various antifungal agents is a risk factor attributed to these types of infections, which instigates the search for new sources of active compounds in vulvovaginal candidiasis (VCC) therapy.

Objective: This study evaluated the antifungal activity of Syngonanthus nitens Bong. (Ruhland) derivatives and employed a lipid nanoemulsion as a delivery system.'

Methods: In this study, a lipid nanoemulsion was employed as a delivery system composed of Cholesterol (10%), soybean phosphatidylcholine: Brij 58 (1: 2) and PBS (pH 7.4) with the addition of 0.5% of a chitosan dispersion (80%), and evaluated the antifungal activity of S. nitens Bong. (Ruhland) derivatives against planktonic cells and biofilms of Candida parapsilosis. By a biomonitoring fractionation, the crude extract (EXT) and one fraction (F2) were selected and incorporated into a lipid nanoemulsion (NL) composed of cholesterol (10%), a 1:2 mixture of soybean phosphatidylcholine:polyoxyethylene -20- cetyl ether (10%), and phosphate buffer solution (pH 7.4) with a 0.5% chitosan dispersion (80%). The NL presented a diameter size between 50-200 nm, pseudoplastic behavior, and positive charge. The EXT and five fractions were active against planktonic cells.

Results and Discussion: The incorporation of EXT and F2 into the NL increased antifungal activity and enhanced the anti-biofilm potential. This study classified the use of an NL as an important tool for the administration of S. nitens derivatives in cases of infections caused by this C. parapsisilosis.

Conclusion: This work concluded that S. nitens derivatives were important sources of active molecules against C. parapsilosis and the use of a lipid nanoemulsion was an important tool to promote more effective F2 release and to improve the antifungal activity aiming the control of C. parapsilosis infections.

Keywords: Syngonanthus nitens, Candida sp, lipid nanoemulsion, Candida parapsilosis, vulvovaginal candidiasis, antifungal

[1]
Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 2016; 214(1): 15-21.
[http://dx.doi.org/10.1016/j.ajog.2015.06.067] [PMID: 26164695]
[2]
Brandolt TM, Klafke GB, Gonçalves CV, et al. Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates. Braz J Microbiol 2017; 48(1): 145-50.
[http://dx.doi.org/10.1016/j.bjm.2016.09.006] [PMID: 27756539]
[3]
Brilhante RSN, Sales JA, da Silva MLQ, et al. Antifungal susceptibility and virulence of Candida parapsilosis species complex: an overview of their pathogenic potential. J Med Microbiol 2018; 67(7): 903-14.
[http://dx.doi.org/10.1099/jmm.0.000756] [PMID: 29846153]
[4]
Pammi M, Holland L, Butler G, Gacser A, Bliss JM. Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis. Pediatr Infect Dis J 2013; 32(5): e206-16.
[http://dx.doi.org/10.1097/INF.0b013e3182863a1c] [PMID: 23340551]
[5]
Öncü B, Belet N, Emecen AN, Birinci A. Health care-associated invasive Candida infections in children. Med Mycol 2019; 57(8): 929-36.
[http://dx.doi.org/10.1093/mmy/myz005] [PMID: 30895305]
[6]
Tóth R, Nosek J, Mora-Montes HM, et al. Candida parapsilosis: from genes to the bedside. Clin Microbiol Rev 2019; 32(2): 1-38.
[http://dx.doi.org/10.1128/CMR.00111-18] [PMID: 30814115]
[7]
Pacifico M, Napolitano A, Masullo M, et al. Metabolite fingerprint of “capim dourado” (Syngonanthus Nitens), a basis of Brazilian handcrafts. Ind Crops Prod 2011; 33: 488-96.
[http://dx.doi.org/10.1016/j.indcrop.2010.10.023]
[8]
Dos Santos Ramos MA, de Toledo LG, Calixto GMF, et al. Syngonanthus nitens Bong. (Rhul.)-loaded nanostructured system for vulvovaginal candidiasis treatment. Int J Mol Sci 2016; 17(8): 1368-87.
[http://dx.doi.org/10.3390/ijms17081368] [PMID: 27556451]
[9]
Dos Santos Ramos MA, da Silva PB, de Toledo LG, et al. Intravaginal delivery of Syngonanthus nitens (Bong.) Ruhland fraction based on a nanoemulsion system applied to vulvovaginal candidiasis treatment. J Biomed Nanotechnol 2019; 15(5): 1072-89.
[http://dx.doi.org/10.1166/jbn.2019.2750] [PMID: 30890237]
[10]
dos Santos Ramos MA, Calixto G, de Toledo LG, et al. Liquid crystal precursor mucoadhesive system as a strategy to improve the prophylactic action of Syngonanthus nitens (Bong.) Ruhland against infection by Candida krusei. Int J Nanomedicine 2015; 10: 7455-66.
[http://dx.doi.org/10.2147/IJN.S92638] [PMID: 26719688]
[11]
da Silva PB, Ramos MAS, Bonifácio BV, et al. Nanotechnological strategies for vaginal administration of drugs--a review. J Biomed Nanotechnol 2014; 10(9): 2218-43.
[http://dx.doi.org/10.1166/jbn.2014.1890] [PMID: 25992455]
[12]
Bonifácio BV, Ramos MAS, da Silva PB, et al. Nanostructured lipid system as a strategy to improve the anti-Candida albicans activity of Astronium sp. Int J Nanomedicine 2015; 10: 5081-92.
[http://dx.doi.org/10.2147/IJN.S79684] [PMID: 26300640]
[13]
Bonifácio BV, Silva PB, Ramos MAS, Negri KMS, Bauab TM, Chorilli M. Nanotechnology-based drug delivery systems and herbal medicines: a review. Int J Nanomedicine 2014; 9: 1-15.
[PMID: 24363556]
[14]
Dos Santos Ramos MA, Da Silva PB, Spósito L, et al. Nanotechnology-based drug delivery systems for control of microbial biofilms: a review. Int J Nanomedicine 2018; 13: 1179-213.
[http://dx.doi.org/10.2147/IJN.S146195] [PMID: 29520143]
[15]
Mahato R. Nanoemulsion as targeted drug delivery system for cancer therapeutics. J Pharm Sci 2017; 3: 83-97.
[16]
CLSI Manual Clinical and Laboratory Standards Institute.. Reference methods for broth dilution antifungal susceptibility tests for yeasts, approved standards-6a ed In: Wayne, PA: Document M27- A3, Clinical and Laboratory Standards Institute 2008.
[17]
Eloy JO, Petrilli R, Topan JF, et al. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Colloids Surf B Biointerfaces 2016; 141: 74-82.
[http://dx.doi.org/10.1016/j.colsurfb.2016.01.032] [PMID: 26836480]
[18]
Rodero CF, Fioramonti Calixto GM, Cristina Dos Santos K, et al. Curcumin-loaded liquid crystalline systems for controlled drug release and improved treatment of vulvovaginal candidiasis. Mol Pharm 2018; 15(10): 4491-504.
[http://dx.doi.org/10.1021/acs.molpharmaceut.8b00507] [PMID: 30184431]
[19]
da Silva PB, Bonifácio BV, Frem RCG, et al. A Nanostructured lipid system as a strategy to improve the in vitro antibacterial activity of copper(II) complexes. Molecules 2015; 20(12): 22534-45.
[http://dx.doi.org/10.3390/molecules201219822] [PMID: 26694337]
[20]
Zorzi GK, Caregnato F, Moreira JCF, Teixeira HF, Carvalho ELS. Antioxidant effect of nanoemulsions containing extract of Achyrocline satureioides (Lam) D.C.-Asteraceae. AAPS PharmSciTech 2016; 17(4): 844-50.
[http://dx.doi.org/10.1208/s12249-015-0408-8] [PMID: 26361953]
[21]
Salmazi R, Calixto G, Bernegossi J, Ramos MA, Bauab TM, Chorilli M. A curcumin-loaded liquid crystal precursor mucoadhesive system for the treatment of vaginal candidiasis. Int J Nanomedicine 2015; 10: 4815-24.
[PMID: 26257519]
[22]
Saxena A, Kaloti M, Bohidar HB. Rheological properties of binary and ternary protein-polysaccharide co-hydrogels and comparative release kinetics of salbutamol sulphate from their matrices. Int J Biol Macromol 2011; 48(2): 263-70.
[http://dx.doi.org/10.1016/j.ijbiomac.2010.11.008] [PMID: 21108963]
[23]
Shaikh R, Raj Singh TR, Garland MJ, Woolfson AD, Donnelly RF. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci 2011; 3(1): 89-100.
[http://dx.doi.org/10.4103/0975-7406.76478] [PMID: 21430958]
[24]
De Toledo LG, Ramos MAS, Spósito L, et al. Essential oil of Cymbopogon nardus (L.) Rendle: a strategy to combat fungal infections caused by Candida species. Int J Mol Sci 2016; 17(8): 1252-68.
[http://dx.doi.org/10.3390/ijms17081252] [PMID: 27517903]
[25]
Pitangui NS, Sardi JCO, Silva JF, et al. Adhesion of Histoplasma capsulatum to pneumocytes and biofilm formation on an abiotic surface. Biofouling 2012; 28(7): 711-8.
[http://dx.doi.org/10.1080/08927014.2012.703659] [PMID: 22784100]
[26]
Seleem D, Pardi V, Murata RM. Review of flavonoids: A diverse group of natural compounds with anti-Candida albicans activity in vitro. Arch Oral Biol 2017; 76: 76-83.
[http://dx.doi.org/10.1016/j.archoralbio.2016.08.030] [PMID: 27659902]
[27]
Shafaghat A, Pirfarshi F, Shafaghatlonbar M. Luteolin derivatives and antimicrobial activity of Achillea tenuifolia Lam. methanol extract. Ind Crops Prod 2014; 62: 533-6.
[http://dx.doi.org/10.1016/j.indcrop.2014.09.016]
[28]
López-Lázaro M. Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem 2009; 9(1): 31-59.
[http://dx.doi.org/10.2174/138955709787001712] [PMID: 19149659]
[29]
Joung DK, Kang OH, Seo YS, et al. Luteolin potentiates the effects of aminoglycoside and β-lactam antibiotics against methicillin-resistant Staphylococcus aureus in vitro. Exp Ther Med 2016; 11(6): 2597-601.
[http://dx.doi.org/10.3892/etm.2016.3212] [PMID: 27284353]
[30]
de Freitas Araújo MG, Pacífico M, Vilegas W, et al. Evaluation of Syngonanthus nitens (Bong.) Ruhl. extract as antifungal and in treatment of vulvovaginal candidiasis. Med Mycol 2013; 51(7): 673-82.
[http://dx.doi.org/10.3109/13693786.2013.795294] [PMID: 23758104]
[31]
de Oliveira AP, de Sousa JF, da Silva MA, et al. Estrogenic and chemopreventive activities of xanthones and flavones of Syngonanthus (Eriocaulaceae). Steroids 2013; 78(11): 1053-63.
[http://dx.doi.org/10.1016/j.steroids.2013.07.002] [PMID: 23891669]
[32]
Echeverría J, Duarte Galhardo de Albuquerque RD. Nanoemulsions of essential oils: new tool for control of vector-borne diseases and in vitro effects on some parasitic agents. Medicines (Basel) 2019; 6(2): 42-53.
[http://dx.doi.org/10.3390/medicines6020042] [PMID: 30934720]
[33]
Nastiti CMRR, Ponto T, Abd E, Grice JE, Benson HAE, Roberts MS. Topical nano and microemulsions for skin delivery. Pharmaceutics 2017; 9(4): 1-25.
[http://dx.doi.org/10.3390/pharmaceutics9040037] [PMID: 28934172]
[34]
Mazia RS, de Araújo Pereira RR, de Francisco LM, et al. Formulation and evaluation of a mucoadhesive thermoresponsive system containing Brazilian green propolis for the treatment of lesions caused by herpes simplex type I. J Pharm Sci 2016; 105(1): 113-21.
[http://dx.doi.org/10.1016/j.xphs.2015.11.016] [PMID: 26852846]
[35]
Suñer-Carbó J, Boix-Montañés A, Halbaut-Bellowa L, et al. Skin permeation of econazole nitrate formulated in an enhanced hydrophilic multiple emulsion. Mycoses 2017; 60(3): 166-77.
[http://dx.doi.org/10.1111/myc.12575] [PMID: 27761948]
[36]
Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 2012; 36(2): 288-305.
[http://dx.doi.org/10.1111/j.1574-6976.2011.00278.x] [PMID: 21569057]
[37]
Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence 2013; 4(2): 119-28.
[http://dx.doi.org/10.4161/viru.22913] [PMID: 23302789]
[38]
Rizzello L, Cingolani R, Pompa PP. Nanotechnology tools for antibacterial materials. Nanomedicine (Lond) 2013; 8(5): 807-21.
[http://dx.doi.org/10.2217/nnm.13.63] [PMID: 23656266]
[39]
Sadekuzzaman M, Yang S, Mizan MFR, Ha SD. Current and recent advanced strategies for combating biofilms. Compr Rev Food Sci Food Saf 2015; 14: 491-509.
[http://dx.doi.org/10.1111/1541-4337.12144]
[40]
Gharenaghadeh S, Karimi N, Forghani S, et al. Application of Salvia multicaulis essential oil-containing nanoemulsion against food-borne pathogens. Food Biosci 2017; 19: 128-33.
[http://dx.doi.org/10.1016/j.fbio.2017.07.003]